文献速递运动医学

羊膜与脐带来源产品在运动医学中的应用:从基础科学到临床应用

Amnion and Umbilical Cord-Derived Products in Sports Medicine: From Basic Science to Clinical Application.
PubMed 文献 · Am J Sports Med · 2021-04-30

该研究通过实验室检测分析了一份脐带血产品,并与制造商报告的数据进行比较。结果显示产品细胞活力低于制造商报告,细胞主要为白细胞,无干细胞存在,IL-1ra浓度因非特异性抗体结合而假性升高。作者建议医疗专业人员在评估出生组织产品时,应理解荧光染料、细胞类型鉴定、干细胞标志物及ELISA检测的局限性。

要点

  • 出生组织产品中「细胞」不一定是干细胞,需通过显微镜或血常规确定细胞类型。
  • 荧光染料评估细胞活力时,绿色不一定代表活细胞,需理解染料原理。
  • 流式细胞术中无单一CD标志物可鉴定干细胞。

核心结论

  • 医疗专业人员在评估出生组织产品时,应谨慎解读细胞活力、细胞类型、干细胞分析和生长因子数据,避免被误导。

研究设计与样本

  • 描述性实验室研究与专家意见,证据等级为5级。

主要发现

  • 脐带血产品的细胞活力低于制造商报告。
  • 产品中的细胞主要为白细胞,未检测到干细胞。
  • IL-1ra浓度因样本中非特异性抗体结合而假性升高。

关键数值与推荐

  • 评估细胞活力需理解荧光染料,绿色不一定代表活细胞。
  • 报告中的「细胞」不一定是「干细胞」,应通过至少×20显微镜图像或血常规确定细胞类型。
  • 流式细胞术中无单一CD标志物可鉴定干细胞。
  • ELISA检测生长因子可能因非特异性结合而假性升高,且大多数ELISA并非为生物制品设计或验证。
  • 生长因子的报告测量值应结合天然生物组织和血浆中的浓度来考虑。

临床怎么用

  • 在考虑使用出生组织产品时,应能解读细胞活力、细胞形态、基于CD标志物的干细胞分析以及生长因子分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Birth tissue products from amnion, chorion, umbilical cord, amniotic fluid, or cord blood are frequently marketed as viable sources of stem cells and growth factors. It can be difficult for health care professionals to differentiate implied from explicit conclusions in reported product analyses. PURPOSE: To provide an educational platform for health care professionals to interpret data presented in the promotion of birth tissue products. STUDY DESIGN: Descriptive laboratory study and expert opinion; Level of evidence, 5. METHODS: A cord blood product was analyzed by 3 methods for cell viability, 2 methods for assessment of cell morphology and cell type, multicolor flow cytometry to identify stem cells, and enzyme-linked immunosorbent assay (ELISA) plus Western blot for analysis of interleukin 1 receptor antagonist protein (IL-1ra). These data were compared with analyses reported by the manufacturer. RESULTS: Cell viability in the cord blood product was less than reported by the manufacturer, the cells were primarily leukocytes, no stem cells were present, and the concentration of IL-1ra was falsely increased due to nonspecific antibody binding in the sample. CONCLUSION: To assess birth tissue products, health care professionals should consider the following: (1) Understanding fluorescent dyes is important for assessing cell viability data-green does not always mean alive. (2) The report of "cells" in the product does not necessarily mean "stem cells"; microscopic images of at least ×20 or a hemogram should be evaluated to determine cell type (leukocyte, red blood cells, etc). (3) There is no single cluster of differentiation (CD) marker on flow cytometry to identify stem cells. (4) Biological tissues are complex substances, and inaccurately increased measurements of growth factors could be present in ELISA results because most ELISAs are not designed or validated for use in biologics. Furthermore, the reported measurement of growth factors should be considered relative to concentrations in native biological tissues and plasma. CLINICAL RELEVANCE: Health care professionals should be able to interpret cell viability, cell morphology, stem cell analysis using CD markers, and growth factor analysis when considering use of a birth tissue product in patients.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Fortier LA, Cercone M, Keller LE, et al. Amnion and Umbilical Cord-Derived Products in Sports Medicine: From Basic Science to Clinical Application. Am J Sports Med. 2021. PMID: 33929908. doi:10.1177/03635465211010466

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。